Čájehuvvojit 1 - 6 oktiibuot 6 bohtosis ohcui Birgit Geoerger (14952291)', ohcanáigi: 0,01s
Aiddostahte ozu
-
1
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models Dahkki Elizabeth R. Tucker (15053624)
Almmustuhtton 2025Eará dahkkit: -
2
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models Dahkki Elizabeth R. Tucker (15053624)
Almmustuhtton 2025Eará dahkkit: -
3
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models Dahkki Elizabeth R. Tucker (15053624)
Almmustuhtton 2025Eará dahkkit: -
4
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models Dahkki Elizabeth R. Tucker (15053624)
Almmustuhtton 2025Eará dahkkit: -
5
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models Dahkki Elizabeth R. Tucker (15053624)
Almmustuhtton 2025Eará dahkkit: -
6
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models Dahkki Elizabeth R. Tucker (15053624)
Almmustuhtton 2025Eará dahkkit: